Eric Sheldon

2.3k total citations
37 papers, 1.6k citations indexed

About

Eric Sheldon is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Eric Sheldon has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Pharmacology and 8 papers in Infectious Diseases. Recurrent topics in Eric Sheldon's work include Influenza Virus Research Studies (11 papers), Inflammatory mediators and NSAID effects (11 papers) and Respiratory viral infections research (10 papers). Eric Sheldon is often cited by papers focused on Influenza Virus Research Studies (11 papers), Inflammatory mediators and NSAID effects (11 papers) and Respiratory viral infections research (10 papers). Eric Sheldon collaborates with scholars based in United States, Canada and Belgium. Eric Sheldon's co-authors include Mark M. Blatter, Eric Plennevaux, Martine Denis, Francis X. Burch, Louis Fries, George Risi, Nachiket Patel, C. Codding, C. Birbara and Howard Schwartz and has published in prestigious journals such as The Lancet, Spine and The Journal of Infectious Diseases.

In The Last Decade

Eric Sheldon

37 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Eric Sheldon	758	397	366	334	242	37	1.6k
Giovanni Matera	475 0.6×	285 0.7×	108 0.3×	393 1.2×	333 1.4×	128	1.6k
Neena Khanna	396 0.5×	392 1.0×	150 0.4×	365 1.1×	171 0.7×	149	1.7k
Shuji Hatakeyama	782 1.0×	467 1.2×	115 0.3×	125 0.4×	179 0.7×	102	1.3k
Hongmei Xu	496 0.7×	338 0.9×	43 0.1×	170 0.5×	272 1.1×	85	1.3k
Claudius U. Meyer	665 0.9×	239 0.6×	160 0.4×	289 0.9×	276 1.1×	56	1.4k
Jo Ellen Schweinle	572 0.8×	179 0.5×	73 0.2×	334 1.0×	153 0.6×	22	1.2k
Dimitrios Farmakiotis	1.1k 1.4×	1.2k 2.9×	170 0.5×	121 0.4×	265 1.1×	107	2.9k
Anand Shah	256 0.3×	511 1.3×	65 0.2×	194 0.6×	218 0.9×	91	1.4k
Darwin L. Palmer	638 0.8×	534 1.3×	111 0.3×	250 0.7×	130 0.5×	50	2.0k
Alfredo Focà	823 1.1×	310 0.8×	53 0.1×	255 0.8×	257 1.1×	109	1.9k

Countries citing papers authored by Eric Sheldon

Since Specialization

Citations

This map shows the geographic impact of Eric Sheldon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Sheldon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Sheldon more than expected).

Fields of papers citing papers by Eric Sheldon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Sheldon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Sheldon. The network helps show where Eric Sheldon may publish in the future.

Co-authorship network of co-authors of Eric Sheldon

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Sheldon. A scholar is included among the top collaborators of Eric Sheldon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Sheldon. Eric Sheldon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pichon, Sylvie, et al.. (2023). Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults. Vaccine. 42(10). 2553–2559. 2 indexed citations

Frenck, Robert W., C. Buddy Creech, Eric Sheldon, et al.. (2016). Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study. Vaccine. 35(2). 375–384. 51 indexed citations

Hopkins, Robert J., et al.. (2016). Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults. Vaccine. 34(18). 2096–2105. 39 indexed citations

Creech, C. Buddy, Robert W. Frenck, Eric Sheldon, et al.. (2016). Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial. Vaccine. 35(2). 385–394. 43 indexed citations

Falloon, Judith, Fei Ji, Craig Curtis, et al.. (2016). A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant. Vaccine. 34(25). 2847–2854. 50 indexed citations

Sheldon, Eric, Martin Schwickart, Jing Li, et al.. (2016). Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study. Advances in Therapy. 33(2). 225–251. 36 indexed citations

Hopkins, Robert J., et al.. (2014). Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults. Vaccine. 32(19). 2217–2224. 16 indexed citations

Sheldon, Eric, Robert Jeanfreau, Joseph Sliman, et al.. (2012). Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study*. Influenza and Other Respiratory Viruses. 7(6). 1142–1150. 13 indexed citations

Taylor, David N., John J. Treanor, Eric Sheldon, et al.. (2012). Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response. Vaccine. 30(39). 5761–5769. 102 indexed citations

10.

Langley, Joanne M., George Risi, Michael S. Caldwell, et al.. (2011). Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study. The Journal of Infectious Diseases. 203(12). 1729–1738. 65 indexed citations

11.

Langley, Joanne M., Louise Frenette, Linda Ferguson, et al.. (2010). Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults. The Journal of Infectious Diseases. 201(11). 1644–1653. 76 indexed citations

12.

Plennevaux, Eric, et al.. (2009). Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. The Lancet. 375(9708). 41–48. 211 indexed citations

13.

Sheldon, Eric, Steven Bird, Steven S. Smugar, & Andrew M. Tershakovec. (2008). Correlation of Measures of Pain, Function, and Overall Response. Spine. 33(5). 533–538. 19 indexed citations

14.

Kalman, Douglas, et al.. (2008). Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint®) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial. Nutrition Journal. 7(1). 3–3. 49 indexed citations

15.

Birbara, C., Gary Ruoff, Eric Sheldon, et al.. (2005). Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies. Current Medical Research and Opinion. 22(1). 199–210. 20 indexed citations

16.

Wiesenhutter, Craig W., Judith A. Boice, Amy T. Ko, et al.. (2005). Evaluation of the Comparative Efficacy of Etoricoxib and Ibuprofen for Treatment of Patients With Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial. Mayo Clinic Proceedings. 80(4). 470–479. 55 indexed citations

17.

Fleischmann, Roy, et al.. (2005). Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib. Clinical Rheumatology. 25(1). 42–53. 38 indexed citations

18.

Burch, Francis X., C. Codding, Nachiket Patel, & Eric Sheldon. (2004). Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients. Osteoarthritis and Cartilage. 12(3). 253–255. 66 indexed citations

19.

Galer, Bradley S., et al.. (2004). Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Current Medical Research and Opinion. 20(9). 1455–1458. 47 indexed citations

20.

Birbara, C., et al.. (2003). Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability—a randomized, placebo-controlled, 3-month trial. Journal of Pain. 4(6). 307–315. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact